A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions

Advanced Solid Tumors

Interventions

DRUG

[14C]linifanib

\[14C\]linifanib, single administration, oral liquid

DRUG

ABT-869, linifanib

linifanib once a day (QD), oral tablet

Trial Locations (2)

Site Reference ID/Investigator# 40942, Cleveland

Site Reference ID/Investigator# 53663, Cleveland